Seems uniquely good for rapid relief of depression/neuroplasticity. it’s also the safest and most insurance-friendly form of ketamine administration.
(possibly the most accessible way of preventing suicidal crises)
The genuinely interesting newer angle — ketamine alone, via neuronal synchrony. The 2024 Nature paper (Jiang-Xie / Kipnis lineage) used ketamine anesthesia specifically and argued the driver isn’t vascular pulsation but neurons: neural networks synchronize individual action potentials to create large-amplitude, rhythmic, self-perpetuating ionic waves in the interstitial fluid, and when they chemogenetically flattened those waves, cerebrospinal fluid infiltration into and clearance of molecules from the brain parenchyma was largely impeded. They picked ketamine precisely because it has been shown to enhance the glymphatic system at a level comparable to that in natural sleep. Their tagline — neurons that fire together “shower” together. This is a mechanistic claim that ketamine-induced synchronized neuronal activity drives clearance, and it’s somewhat independent of the xylazine confound since they used ketamine. I rate it plausible and interesting (~0.5–0.6) but note this whole convective-flow premise is contested — the same paper concedes the model has been challenged by the lack of a significant pressure gradient between para-arterial and paravenous spaces needed to drive convection. Nature + 3
The part nobody can answer well — sub-anesthetic / antidepressant-dose ketamine. This is probably what you actually care about, and it’s the biggest gap. Everything above is anesthetic dosing (~100 mg/kg in mice). The ketamine humans get in a depression clinic (~0.5 mg/kg infusion) or recreationally is a totally different pharmacological regime: low-dose ketamine increases glutamatergic activity, cortical arousal, gamma power — roughly the opposite of the high-delta, low-arousal slow-wave state that K/X produces and that the clearance literature keeps fingering as the driver. I could not find solid direct data on glymphatic flux under sub-anesthetic ketamine, and I’d flag this hard: extrapolating “K/X boosts mouse glymphatics” → “your ketamine infusion clears amyloid” is, on current evidence, unsupported and arguably backwards. My honest epistemic state here is “I don’t know,” not “I’m choosing between hypotheses” — there may be a paper I’m missing, but the mechanistic logic actively cuts against the naive extrapolation.
So, putting confidences on the table:
Anesthetic K/X raises CSF influx in rodents — fairly likely (~0.8), but heavily xylazine-contaminated as a “ketamine” claim.
K/X improves end-to-end clearance/efflux to lymphatics — genuinely contested (~0.4); at least one study shows reduced lymphatic drainage.
Ketamine-driven neuronal synchrony mechanistically powers clearance — plausible (~0.5), resting on the still-disputed convection model.
Sub-anesthetic/clinical ketamine enhances human glymphatic clearance — can’t support it; mechanism arguably points the other way. This is the claim to be most suspicious of if you see it asserted online.
The mode I’d collapse to if forced — “ketamine enhances glymphatic clearance” — is true-ish only in the narrow rodent-anesthesia, influx-measured, xylazine-confounded sense. The strongest counter, which I find pretty compelling, is that the result is really an α2-agonist + slow-wave-state result wearing a ketamine label, and it tells you little about ketamine as people actually encounter it.
What would sharpen this a lot: a study measuring glymphatic transport (ideally efflux, not just influx) under ketamine without xylazine at sub-anesthetic dose, awake or lightly sedated. If you’ve seen one, send it — that’s the missing keystone. Want me to dig specifically for human DTI-ALPS or ketamine-infusion glymphatic data?
Yes, Better U has substantially better public reviews than Innerwell.
As of late July 2026:
Better U:4.5/5 from 418 Trustpilot reviews
Innerwell:3.0/5 from only 8 Trustpilot reviews
For context, Mindbloom and Joyous are both around 3.8/5, though with far more reviews than Innerwell.
Better U’s positive reviews repeatedly praise responsive staff, affordability, smooth onboarding and meaningful symptom improvement. Its negative reviews cluster around billing disputes, missed or rushed appointments, weak communication and inconsistent medication shipments or perceived potency.
Innerwell jammed so I finally submitted the order for Better U. Lord knows I should have done this way earlier (but I guess I didn’t know mail order ketamine was so cheap and easy)
Had 2 sessions over the past week already!! this really could be the lifechanger for me
Ketamine cystitis is inflammatory and toxic damage to the urothelial lining. Ketamine and its metabolites — norketamine and especially dehydronorketamine — get excreted in urine and are directly cytotoxic to the bladder wall. They strip the protective glycosaminoglycan (GAG) layer, trigger oxidative stress and mast cell activation, and over time can lead to fibrosis and reduced bladder capacity. So the intervention targets are: reduce urothelial exposure, protect the lining, dampen inflammation. Nothing dissolves anything.
The interventions that actually work, ranked honestly:
Highest-yield and boring. Reduce cumulative exposure. This is the only variable with clear evidence — total dose × frequency × duration. Every case series of severe cystitis is heavy chronic users. Hydration is second: aggressive water intake dilutes urinary metabolite concentration and reduces contact time. Not a wellness suggestion — a mechanistically real protective factor. Frequent urination in the same vein; don’t hold it. These three do most of the actual work and none of them are exciting.
Adjuncts with real but limited evidence. Intravesical GAG replenishment (hyaluronic acid or chondroitin sulfate instilled directly into the bladder) has some published evidence in ketamine-induced cystitis specifically — but it’s a urology procedure, not a home intervention. Pentosan polysulfate (Elmiron) is the oral version of GAG-layer support, approved for interstitial cystitis, with a few case reports in KIC. Real caveat: long-term Elmiron has a documented retinal toxicity signal, so it’s not something to take casually or without ophthalmology follow-up. N-acetylcysteine — antioxidant, plausible mechanism, evidence is thin but it’s cheap and low-risk.
[it might be interesting to see a cyclosporine x ketamine study at some pt]
a new study reveals that its effects on the brain are different in male and female mice. This insight—if reproduced in humans—could change the way we test the efficacy of drugs and unlock better treatments for depression.
Researchers at the Institute of Science and Technology Austria, in collaboration with scientists at the Allen Institute, discovered that when female mice are recovering from a single ketamine sedation, their brains become more active than their male counterparts, specifically their microglia. These specialized brain cells began reaching out with their branch-like arms to intermingle with surrounding brain cells. This increased activity led to the removal of the extracellular matrix—the proteins and molecules surrounding, supporting, and giving structure to cells—and created space that allowed new synapses to form and remodel the neural network, thereby increasing neuroplasticity. Researchers didn’t observe this behavior in male mice.
I use Mindbloom, though Joyous seems reasonably priced as well. For me, weekly use has been beneficial.
What frustrates me is that cases like the Matthew Perry situation—and the irresponsible prescribing and medical practices surrounding it—can make things harder for people who are using ketamine responsibly and therapeutically. I imagine we’ll see more scrutiny and oversight of telehealth prescribing as a result.
It’s also frustrating that ketamine itself is an inexpensive, long-established medication, yet access to treatment can be extremely costly. There’s clearly value in medical supervision, screening, and support, but it sometimes feels like a very inexpensive molecule has been packaged into an increasingly expensive business model.
Matthew Petty used illegally sourced ketamine? Way more?
with betterucare you only get a limited supply of trouches each time/they monitor how much you take, and it’s harder to “get high” sublingually than snorting? Though there’s nothing to prevent someone from taking way more than 2 trouches at once (it just makes it harder for you to continually use it like an addict later).